nProfiler I Stomach Cancer Assay Kit
Sponsors
Yonsei University, Novomics. Co., Ltd.
Conditions
Gastric CancerStage II-III Gastric Cancer
Unknown Phase
A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)
CompletedNCT03403296
Start: 2016-07-13End: 2017-07-12Updated: 2018-01-18
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
Active, not recruitingNCT04487717
Start: 2020-07-29End: 2029-12-31Updated: 2024-12-17
Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer
CompletedNCT04600518
Start: 2020-10-07End: 2023-06-22Updated: 2024-07-22
A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test
Active, not recruitingNCT06521528
Start: 2019-09-01End: 2025-12-31Updated: 2024-07-29